scispace - formally typeset
S

Stefan Neubauer

Researcher at University of Oxford

Publications -  709
Citations -  33606

Stefan Neubauer is an academic researcher from University of Oxford. The author has contributed to research in topics: Magnetic resonance imaging & Heart failure. The author has an hindex of 84, co-authored 636 publications receiving 26870 citations. Previous affiliations of Stefan Neubauer include John Radcliffe Hospital & Southampton General Hospital.

Papers
More filters
Journal ArticleDOI

Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges

TL;DR: A significant sex difference in the rate of change exists, with females showing a steeper decline in aortic elasticity, which may explain the increase in cardiovascular event rates that accompanies the menopausal age in women.
Journal ArticleDOI

Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group

TL;DR: The role of the various investigation techniques in the management of coronary artery disease and their resource implications should help determine future service provision, accepting that the authors are in a period of significant technological change.
Journal ArticleDOI

Metabolic remodeling in hypertrophied and failing myocardium: a review.

TL;DR: It is suggested that lack of metabolic flexibility and reserve (substrate, oxidative, and phosphotransfer) represents a final common denominator ultimately compromising efficiency and contractile reserve in stressful contexts.
Journal ArticleDOI

Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI

TL;DR: An improved 3D MRI method is validated to noninvasively quantify infarct size in mice with unsurpassed spatial resolution and tissue contrast, particularly suited to studies requiring early quantification of initial infarCT size, for example, to measure damage before intervention with stem cells.